Particle.news

Download on the App Store

Harvard and Rush to Launch Human Trials After Lithium Orotate Reverses Alzheimer’s in Mice

The decade-long Harvard–Rush study found trace lithium levels fall in early cognitive impairment; low-dose lithium orotate reversed Alzheimer’s pathology in mouse models.

Image
Image
Image

Overview

  • A Nature paper on August 5 reported that trace lithium in the brain diminishes as Alzheimer’s markers rise in mice; low-dose lithium orotate prevented and reversed neuronal damage.
  • Analyses of postmortem brain tissue and blood from people with mild cognitive impairment found lithium to be the only metal significantly depleted compared with healthy individuals.
  • Previous Danish and U.K. environmental studies found that higher lithium levels in drinking water correspond with lower dementia rates.
  • Researchers emphasize that mouse-model success must be validated in human trials and warn against unsupervised lithium supplementation.
  • Harvard and Rush investigators are planning controlled clinical trials and encouraging early lithium-level screening as a possible Alzheimer’s diagnostic tool.